Prevention and Management of Gestational Diabetes Using Vitamin D Supplementation: An Overview and Appraisal of Clinical Trials
Source abstract
Abstract
A number of studies have examined the role of vitamin D in reproductive processes and disorders of pregnancy such as gestational diabetes mellitus (GDM). Although observational studies have linked maternal vitamin D deficiency with a plethora of adverse pregnancy outcomes including GDM, intervention trials generally do not support the use of vitamin D supplementation for GDM prevention or management. This narrative review provides an up-to-date overview and critical appraisal of randomised controlled trials (RCTs) to describe the current state of knowledge regarding the efficacy of vitamin D supplementation for preventing and/or managing GDM. Overall, although RCT data indicates a potential benefit of vitamin D in maternal glycaemic control, results are highly disparate and the data published to date have not conclusively established the efficacy of vitamin D in GDM prevention. There are, however, several limitations within the existing literature, including some considerable challenges that are unique to vitamin D trials, which should be carefully considered in the interpretation of the evidence and design of future studies. For now, many unanswered questions remain, and there is still a need for adequately powered and well-designed trials before routine supplementation can be recommended in the context of GDM.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Gestational Diabetes Research and Management · Vitamin D Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Monash Centre for Health Research and Implementation (MCHRI), School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3168, Australia
References (96)
Show source-provided references
1. Vitamin D for skeletal and non-skeletal health: What we should know10.1016/j.jcot.2019.07.004 ↗
2. Vitamin D and increasing incidence of type 1 diabetes—Evidence for an association?10.1111/j.1463-1326.2010.01211.x ↗
3. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice10.1016/j.autrev.2010.06.009 ↗
4. Randomized trial of vitamin D supplementation to prevent seasonal influenza a in schoolchildren10.3945/ajcn.2009.29094 ↗
5. Vitamin D supplementation for preventing infections in children under five years of age
6. Effect of vitamin D supplementation on non-skeletal disorders: A systematic review of meta-analyses and randomised trials10.1016/S2213-8587(17)30357-1 ↗
7. Vitamin D deficiency: A worldwide problem with health consequences10.1093/ajcn/87.4.1080S ↗
8. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial10.1017/S0007114509992017 ↗
9. Vitamin D deficiency and risk of cardiovascular disease10.1161/CIRCULATIONAHA.107.706127 ↗
10. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma10.1002/ijc.25439 ↗
11. McDonnell, S.L., Baggerly, C., French, C.B., Baggerly, L.L., Garland, C.F., Gorham, E.D., Lappe, J.M., and Heaney, R.P. (2016). Serum 25-hydroxyvitamin D concentrations ≥40 ng/mL are associated with >65% lower cancer risk: Pooled analysis of randomized trial and prospective cohort study. PLoS ONE, 11.10.1371/journal.pone.0152441 ↗
12. Vitamin D is associated with cognitive function in elders receiving home health services10.1093/gerona/glp032 ↗
13. Serum vitamin D and the risk of Parkinson disease10.1001/archneurol.2010.120 ↗
14. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults10.1097/01.JGP.0000240986.74642.7c ↗
15. Developmental vitamin D deficiency and risk of schizophrenia: A 10-year update10.1093/schbul/sbq101 ↗
16. Association of low serum 25-hydroxyvitamin D levels in pregnancy with glucose homeostasis and obstetric and newborn outcomes10.4158/EP12025.OR ↗
17. Maternal vitamin D status and adverse pregnancy outcomes: A systematic review and meta-analysis10.3109/14767058.2013.765849 ↗
18. The role of vitamin D in reproductive health—A trojan horse or the golden fleece?10.3390/nu7064139 ↗
19. Vitamin D in reproductive health and pregnancy10.1055/s-0036-1583529 ↗
20. Vitamin D and cardiometabolic disorders: A review of current evidence, genetic determinants and pathomechanisms10.1111/obr.12793 ↗
21. Vitamin D and inflammation10.1016/j.jbspin.2010.09.018 ↗
22. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis10.1155/2010/351385 ↗
23. Vitamin D and placental-decidual function10.1016/j.jsgi.2004.02.002 ↗
24. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome10.1055/s-2006-948308 ↗
25. Maternal vitamin D deficiency, ethnicity and gestational diabetes10.1111/j.1464-5491.2008.02422.x ↗
26. Serum 25-hydroxyvitamin D and glycated haemoglobin levels in women with gestational diabetes mellitus10.5694/j.1326-5377.2011.tb03000.x ↗
27. Association between early pregnancy vitamin D status and changes in serum lipid profiles throughout pregnancy10.1016/j.metabol.2017.02.004 ↗
28. Vitamin D and hypertension in pregnancy10.25011/cim.v34i3.15187 ↗
29. Early pregnancy vitamin D and patterns of antenatal inflammation in African-American women10.1016/j.jri.2014.09.054 ↗
30. The relationship of hypovitaminosis D and IL-6 in preeclampsia10.1016/j.ajog.2013.09.037 ↗
31. Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size10.1038/ejcn.2008.14 ↗
32. Maternal vitamin D deficiency in early pregnancy is not associated with gestational diabetes mellitus development or pregnancy outcomes in Korean pregnant women in a prospective study10.3177/jnsv.60.269 ↗
33. Vitamin D deficiency increases the risk of gestational diabetes mellitus: A meta-analysis of observational studies10.3390/nu7105398 ↗
34. The relationship between 25-hydroxyvitamin D concentration in early pregnancy and pregnancy outcomes in a large, prospective cohort10.1017/S0007114516003202 ↗
35. Associations of maternal circulating 25-hydroxyvitamin D3 concentration with pregnancy and birth outcomes10.1111/1471-0528.13074 ↗
36. Effects of maternal serum 25-hydroxyvitamin D concentrations in the first trimester on subsequent pregnancy outcomes in an Australian population10.3945/ajcn.113.065672 ↗
37. Favorable effects of vitamin D supplementation on pregnancy outcomes in gestational diabetes: A double blind randomized controlled clinical trial10.1055/s-0034-1394414 ↗
38. Vitamin D supplementation affects serum high-sensitivity c-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women10.3945/jn.113.177550 ↗
39. Vitamin D3-supplemented yogurt drink improves insulin resistance and lipid profiles in women with gestational diabetes mellitus: A randomized double blinded clinical trial10.1159/000447433 ↗
40. The effects of vitamin D supplementation on maternal and neonatal outcome: A randomized clinical trial
41. Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome10.1111/cen.12751 ↗
42. Vitamin D supplementation and the effects on glucose metabolism during pregnancy: A randomized controlled trial10.2337/dc14-0155 ↗
43. Daily cholecalciferol supplementation during pregnancy alters markers of regulatory immunity, inflammation, and clinical outcomes in a randomized controlled trial10.3945/jn.116.231480 ↗
44. The DALI vitamin D randomized controlled trial for gestational diabetes mellitus prevention: No major benefit shown besides vitamin D sufficiency10.1016/j.clnu.2019.04.006 ↗
45. The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes10.1186/s12884-019-2258-y ↗
46. Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: A randomized, double-blind, placebo-controlled trial10.1139/apnm-2017-0521 ↗
47. Effect of vitamin D supplementation on inflammation: Protocol for a systematic review10.1136/bmjopen-2015-010804 ↗
48. Vitamin D: The “sunshine” vitamin
49. Vitamin D-binding protein in pregnancy and reproductive health10.3390/nu12051489 ↗
50. Blood biomarkers of vitamin D status10.1093/ajcn/87.4.1087S ↗
51. Vitamin D status: Measurement, interpretation, and clinical application10.1016/j.annepidem.2007.12.001 ↗
52. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know10.1210/jc.2010-2704 ↗
53. Vitamin D in pregnancy and lactation in humans10.1146/annurev.nutr.012809.104807 ↗
54. Worldwide vitamin D status10.1016/j.beem.2011.06.007 ↗
55. Do studies reporting ‘u’-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?10.1080/19381980.2016.1187349 ↗
56. Vitamin D and cardiometabolic risk factors and diseases
57. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–200410.1001/archinternmed.2008.604 ↗
58. Vitamin D and health in adults in Australia and New Zealand: A position statement10.5694/mja11.10301 ↗
59. Relevance of vitamin D in reproduction10.1093/humrep/des248 ↗
60. New insights into the vitamin D requirements during pregnancy10.1038/boneres.2017.30 ↗
61. Vitamin D and pregnancy: An old problem revisited10.1016/j.beem.2010.05.010 ↗
62. Vitamin D deficiency and supplementation during pregnancy10.1111/j.1365-2265.2008.03403.x ↗
63. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline10.1210/jc.2011-0385 ↗
64. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) (2015). Vitamin and Mineral Supplementation and Pregnancy, RANZCOG.
65. Zhang, C., Qiu, C., Hu, F.B., David, R.M., van Dam, R.M., Bralley, A., and Williams, M.A. (2008). Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE, 3.10.1371/journal.pone.0003753 ↗
66. Maternal vitamin D deficiency increases the risk of preeclampsia10.1210/jc.2007-0718 ↗
67. Relationship between vitamin D and gestational diabetes in overweight or obese pregnant women may be mediated by adiponectin10.1002/mnfr.201700488 ↗
68. (2019). American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019. Diabetes Care, 42, S13–S28.10.2337/dc19-S002 ↗
69. Diabetes and pregnancy10.1016/j.jcjd.2017.10.038 ↗
70. International association of diabetes and pregnancy study groups consensus panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy10.2337/dc10-0719 ↗
71. World Health Organization (2013). Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy, WHO.
72. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993–200910.1007/s10995-014-1553-5 ↗
73. The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia10.5694/j.1326-5377.2011.tb03001.x ↗
74. Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: Study protocol for a randomized controlled trial
75. Vitamin D supplementation for improvement of chronic low-grade inflammation in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials10.1093/nutrit/nux077 ↗
76. Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: A randomized controlled trial10.3892/etm.2016.3515 ↗
77. Obstetric and neonatal outcomes of maternal vitamin D supplementation: Results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women10.1210/jc.2013-3491 ↗
78. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: A double-blind randomized controlled clinical trial10.3945/ajcn.113.072785 ↗
79. The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy10.3109/09513590.2012.752456 ↗
80. Effect of vitamin D supplementation on the incidence of gestational diabetes10.4103/2277-9175.210658 ↗
81. Effects of high-dose vitamin D supplementation on metabolic status and pregnancy outcomes in pregnant women at risk for pre-eclampsia10.1055/s-0035-1548835 ↗
82. The effects of vitamin D plus calcium supplementation on metabolic profiles, biomarkers of inflammation, oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia10.1111/jhn.12339 ↗
83. The effect of vitamin D supplementation on gestational diabetes in high-risk women: Results from a randomized placebo-controlled trial10.4103/1735-1995.175148 ↗
84. Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: A randomised placebo-controlled trial10.1007/s00125-014-3293-x ↗
85. Effects of vitamin D supplementation on metabolic indices and hs-CRP levels in gestational diabetes mellitus patients: A randomized, double-blinded, placebo-controlled clinical trial10.4162/nrp.2016.10.3.328 ↗
86. Limitations of vitamin D supplementation trials: Why observational studies will continue to help determine the role of vitamin D in health10.1016/j.jsbmb.2017.06.006 ↗
87. Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases?10.3390/nu5125127 ↗
88. Quantifying the vitamin D economy10.1093/nutrit/nuu004 ↗
89. Guidelines for optimizing design and analysis of clinical studies of nutrient effects10.1111/nure.12090 ↗
90. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes10.1210/jc.2013-2653 ↗
91. Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness10.1002/jbmr.463 ↗
92. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: A 6-month follow-up pilot study10.1089/bfm.2006.1.59 ↗
93. Vitamin D across the lifecycle: Physiology and biomarkers10.1093/ajcn/88.2.500S ↗
94. Vitamin D during pregnancy: Why observational studies suggest deficiency and interventional studies show no improvement in clinical outcomes? A narrative review10.1007/s40618-015-0363-y ↗
95. Role of magnesium in vitamin D activation and function10.7556/jaoa.2018.037 ↗
96. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level10.1093/ajcn/73.2.288 ↗